相关实验视频

Updated: Jan 13, 2026

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

在急性髓性白血病中,CAR-T疗法是否有未来?

Caterina Alati¹, Martina Pitea¹, Matteo Molica²

¹Hematology and Stem Cell Transplantation and Cellular Therapies Unit (CTMO), Department of Hemato-Oncology and Radiotherapy, Grande Ospedale Metropolitano "Bianchi-Melacrino-Morelli", 89133 Reggio Calabria, Italy.

|January 10, 2026

概括

复发性和耐药性急性髓性白血病 (AML) 由于瘤微环境和缺乏特定点, presents显著的治疗挑战. 目前的CAR-T细胞疗法在有效治疗这种侵袭性白血病方面遇到了障碍.

科学领域:

血液学血液学血液学
在瘤学瘤学.
免疫治疗是一种免疫疗法.

背景情况:

急性髓性白血病 (AML) 是一种具有高复发率的侵袭性血液癌症.
复发性和耐药性 (R/R) AML 预后不佳,尽管治疗进展,但生存率有限.
缺乏针对R/RAML的有效免疫疗法,使患者的治疗复杂化.

研究的目的:

探索阻碍R/RAML有效CAR-T细胞治疗的挑战.
了解骨髓瘤微环境 (TME) 对CAR-T细胞疗效的影响.
确定FDA批准的AMLCAR-T疗法缺失的原因.

主要方法:

关于AML治疗和免疫治疗的当前文献的综述.
分析R/R AML瘤微环境所带来的生物障碍.
在AML中检查抗原标和CAR-T细胞限制.

主要成果:

在R / RAML中的TME创造了一个免疫抑制和代谢具有挑战性的环境.
这种TME损害了CAR-T细胞的扩张,持久性和细胞毒性功能.
与B细胞ALL不同,AML缺乏真正的白血病特异性抗原,使CAR-T标选择复杂化.

结论:

显著的生物学和与目标相关的挑战阻碍了在R/R AML中CAR-T治疗的成功.
需要多方面的治疗策略来克服TME障碍.
需要进一步的研究来开发有效的CAR-T细胞治疗AML.

关键词:

在AML,AML就是AML.卡特-T疗法是一种治疗方法.急性骨髓性白血病 (AML) 是一种急性骨髓性白血病.白血病特定抗原的抗原.治疗治疗治疗治疗治疗治疗瘤微环境是一个微环境.

更多相关视频

Enhancing Chimeric Antigen Receptor-Extracellular Vesicles (CAR-EV) Technology: The Future of Cancer Therapy

Enhancing Chimeric Antigen Receptor-Extracellular Vesicles (CAR-EV) Technology: The Future of Cancer Therapy

Published on: September 19, 2025

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.